Edition:
United States

ESSA Pharma Inc (EPIX.OQ)

EPIX.OQ on NASDAQ Stock Exchange Capital Market

0.22USD
13 Dec 2017
Change (% chg)

$0.01 (+4.76%)
Prev Close
$0.21
Open
$0.22
Day's High
$0.22
Day's Low
$0.22
Volume
100
Avg. Vol
31,030
52-wk High
$3.59
52-wk Low
$0.21

Chart for

About

ESSA Pharma Inc. is a Canada-based clinical-stage development pharmaceutical company. The Company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer (CRPC). The Company is developing drugs, which selectively block the amino-terminal domain (NTD) of the androgen... (more)

Overall

Beta: --
Market Cap(Mil.): $10.60
Shares Outstanding(Mil.): 29.10
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-Essa Pharma Announces Pricing Of Previously Announced Equity Offering

* ESSA PHARMA ANNOUNCES PRICING OF PREVIOUSLY ANNOUNCED EQUITY OFFERING

Dec 13 2017

BRIEF-ESSA Pharma announces overnight marketed equity offering

* ESSA PHARMA - TO USE NET PROCEEDS OF OFFERING PRIMARILY TO CONTINUE ONGOING PRECLINICAL DEVELOPMENT OF CO'S ANITEN COMPOUNDS Source text for Eikon: Further company coverage:

Dec 12 2017

BRIEF-Essa Pharma Reports Qtrly Loss Per Share Of $0.07

* ESSA PHARMA ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2017

Dec 11 2017

Earnings vs. Estimates